• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.

作者信息

Doran A R, Labarca R, Wolkowitz O M, Roy A, Douillet P, Pickar D

机构信息

Section of Clinical Studies, National Institute of Mental Health, Bethesda, Md. 20892.

出版信息

Arch Gen Psychiatry. 1990 Jun;47(6):558-63. doi: 10.1001/archpsyc.1990.01810180058009.

DOI:10.1001/archpsyc.1990.01810180058009
PMID:2350208
Abstract

Plasma homovanillic acid (HVA) levels were measured hourly for a 24-hour period in 10 patients with schizophrenia during treatment with placebo and fluphenazine. Ten age- and sex-matched normal volunteers were similarly studied. Diet and activity were carefully controlled and monitored in both patients and controls. A circadian rhythm of the plasma HVA level was found in controls with a nadir in the afternoon and peak values in the early morning hours; when the patients were free from drugs, they showed a similar rhythm with lower amplitudes. Fluphenazine treatment significantly reduced the plasma concentrations of HVA and abolished the 24-hour rhythm. These data suggest that a 24-hour rhythm of the plasma HVA level exists in humans and that the amplitude of this rhythm may be less pronounced in patients with schizophrenia. Treatment with neuroleptic drugs reduces both the absolute levels and the normal circadian rhythm of the plasma HVA level.

摘要

相似文献

1
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
Arch Gen Psychiatry. 1990 Jun;47(6):558-63. doi: 10.1001/archpsyc.1990.01810180058009.
2
Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.抗精神病药物引起的精神分裂症患者血浆高香草酸降低及抗精神病活性
Science. 1984 Aug 31;225(4665):954-7. doi: 10.1126/science.6474162.
3
Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
Arch Gen Psychiatry. 1986 Jul;43(7):669-76. doi: 10.1001/archpsyc.1986.01800070059008.
4
The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
Life Sci. 1991;48(14):1411-6. doi: 10.1016/0024-3205(91)90438-h.
5
Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects.
Psychiatry Res. 1993 May;47(2):141-9. doi: 10.1016/0165-1781(93)90044-h.
6
A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
Arch Gen Psychiatry. 1988 Jun;45(6):561-3. doi: 10.1001/archpsyc.1988.01800300057006.
7
Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume.代谢紊乱对精神分裂症患者血浆高香草酸的影响。与前额叶皮质体积的关系。
Arch Gen Psychiatry. 1993 Jul;50(7):541-50. doi: 10.1001/archpsyc.1993.01820190043005.
8
Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
Life Sci. 1989;44(16):1117-21. doi: 10.1016/0024-3205(89)90339-1.
9
Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA.
Biol Psychiatry. 1989 Feb 15;25(4):431-9. doi: 10.1016/0006-3223(89)90196-0.
10
Plasma homovanillic acid as a predictor of response to fluphenazine treatment.
Psychopharmacol Bull. 1989;25(1):89-91.

引用本文的文献

1
The Mind After Midnight: Nocturnal Wakefulness, Behavioral Dysregulation, and Psychopathology.午夜后的心智:夜间觉醒、行为失调与精神病理学
Front Netw Physiol. 2022;1. doi: 10.3389/fnetp.2021.830338. Epub 2022 Mar 3.
2
Fluphenazine (oral) versus placebo for schizophrenia.口服氟奋乃静与安慰剂治疗精神分裂症的比较。
Cochrane Database Syst Rev. 2018 Jun 12;6(6):CD006352. doi: 10.1002/14651858.CD006352.pub3.
3
A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures.帕金森病患者睡眠及其障碍与不同脑结构的关系综述
Front Aging Neurosci. 2016 May 23;8:114. doi: 10.3389/fnagi.2016.00114. eCollection 2016.
4
Fluphenazine (oral) versus placebo for schizophrenia.口服氟奋乃静治疗精神分裂症与安慰剂对照
Cochrane Database Syst Rev. 2013 Jul 17;7(7):CD006352. doi: 10.1002/14651858.CD006352.pub2.